These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1161 related articles for article (PubMed ID: 30991027)

  • 1. Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia.
    Huang Y; Su R; Sheng Y; Dong L; Dong Z; Xu H; Ni T; Zhang ZS; Zhang T; Li C; Han L; Zhu Z; Lian F; Wei J; Deng Q; Wang Y; Wunderlich M; Gao Z; Pan G; Zhong D; Zhou H; Zhang N; Gan J; Jiang H; Mulloy JC; Qian Z; Chen J; Yang CG
    Cancer Cell; 2019 Apr; 35(4):677-691.e10. PubMed ID: 30991027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saikosaponin D exhibits anti-leukemic activity by targeting FTO/m
    Sun K; Du Y; Hou Y; Zhao M; Li J; Du Y; Zhang L; Chen C; Yang H; Yan F; Su R
    Theranostics; 2021; 11(12):5831-5846. PubMed ID: 33897884
    [No Abstract]   [Full Text] [Related]  

  • 3. R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m
    Qing Y; Dong L; Gao L; Li C; Li Y; Han L; Prince E; Tan B; Deng X; Wetzel C; Shen C; Gao M; Chen Z; Li W; Zhang B; Braas D; Ten Hoeve J; Sanchez GJ; Chen H; Chan LN; Chen CW; Ann D; Jiang L; Müschen M; Marcucci G; Plas DR; Li Z; Su R; Chen J
    Mol Cell; 2021 Mar; 81(5):922-939.e9. PubMed ID: 33434505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical Inhibitors Targeting the Oncogenic m
    Huang Y; Xia W; Dong Z; Yang CG
    Acc Chem Res; 2023 Nov; 56(21):3010-3022. PubMed ID: 37889223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-Activity Relationships and Antileukemia Effects of the Tricyclic Benzoic Acid FTO Inhibitors.
    Liu Z; Duan Z; Zhang D; Xiao P; Zhang T; Xu H; Wang CH; Rao GW; Gan J; Huang Y; Yang CG; Dong Z
    J Med Chem; 2022 Aug; 65(15):10638-10654. PubMed ID: 35793358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia.
    Li Y; Zhang M; Sheng M; Zhang P; Chen Z; Xing W; Bai J; Cheng T; Yang FC; Zhou Y
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1065-1077. PubMed ID: 29594337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural characteristics of small-molecule inhibitors targeting
    Gao S; Li X; Zhang M; Zhang N; Wang R; Chang J
    Future Med Chem; 2021 Sep; 13(17):1475-1489. PubMed ID: 34240624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhein exerts anti-multidrug resistance in acute myeloid leukemia via targeting FTO to inhibit AKT/mTOR.
    Zhang S; Zhou L; Yang J; Lu J; Tao L; Feng Y; Cheng J; Zhao L
    Anticancer Drugs; 2024 Aug; 35(7):597-605. PubMed ID: 38728095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational Design of RNA Demethylase FTO Inhibitors with Enhanced Antileukemia Drug-Like Properties.
    Xiao P; Duan Z; Liu Z; Chen L; Zhang D; Liu L; Zhou C; Gan J; Dong Z; Yang CG
    J Med Chem; 2023 Jul; 66(14):9731-9752. PubMed ID: 37418628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N
    Li Z; Weng H; Su R; Weng X; Zuo Z; Li C; Huang H; Nachtergaele S; Dong L; Hu C; Qin X; Tang L; Wang Y; Hong GM; Huang H; Wang X; Chen P; Gurbuxani S; Arnovitz S; Li Y; Li S; Strong J; Neilly MB; Larson RA; Jiang X; Zhang P; Jin J; He C; Chen J
    Cancer Cell; 2017 Jan; 31(1):127-141. PubMed ID: 28017614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. m
    Huff S; Tiwari SK; Gonzalez GM; Wang Y; Rana TM
    ACS Chem Biol; 2021 Feb; 16(2):324-333. PubMed ID: 33412003
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeting FTO suppresses hepatocellular carcinoma by inhibiting ERBB3 and TUBB4A expression.
    Jiang L; Liang R; Luo Q; Chen Z; Song G
    Biochem Pharmacol; 2024 Aug; 226():116375. PubMed ID: 38906227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Yin and Yang of RNA Methylation: An Imbalance of Erasers Enhances Sensitivity to FTO Demethylase Small-Molecule Targeting in Leukemia Stem Cells.
    Van Der Werf I; Jamieson C
    Cancer Cell; 2019 Apr; 35(4):540-541. PubMed ID: 30991023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Research Progress of m6A Demethylase FTO and Its Inhibitors in Acute Myeloid Leukemia --Review].
    Fang ZH; Zheng SY; Feng WY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):902-906. PubMed ID: 37356958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion.
    Su R; Dong L; Li Y; Gao M; Han L; Wunderlich M; Deng X; Li H; Huang Y; Gao L; Li C; Zhao Z; Robinson S; Tan B; Qing Y; Qin X; Prince E; Xie J; Qin H; Li W; Shen C; Sun J; Kulkarni P; Weng H; Huang H; Chen Z; Zhang B; Wu X; Olsen MJ; Müschen M; Marcucci G; Salgia R; Li L; Fathi AT; Li Z; Mulloy JC; Wei M; Horne D; Chen J
    Cancer Cell; 2020 Jul; 38(1):79-96.e11. PubMed ID: 32531268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cabozantinib is selectively cytotoxic in acute myeloid leukemia cells with FLT3-internal tandem duplication (FLT3-ITD).
    Lu JW; Wang AN; Liao HA; Chen CY; Hou HA; Hu CY; Tien HF; Ou DL; Lin LI
    Cancer Lett; 2016 Jul; 376(2):218-25. PubMed ID: 27060207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDC25A governs proliferation and differentiation of FLT3-ITD acute myeloid leukemia.
    Bertoli S; Boutzen H; David L; Larrue C; Vergez F; Fernandez-Vidal A; Yuan L; Hospital MA; Tamburini J; Demur C; Delabesse E; Saland E; Sarry JE; Galcera MO; Mansat-De Mas V; Didier C; Dozier C; Récher C; Manenti S
    Oncotarget; 2015 Nov; 6(35):38061-78. PubMed ID: 26515730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione-Bioimprinted Nanoparticles Targeting of N6-methyladenosine FTO Demethylase as a Strategy against Leukemic Stem Cells.
    Cao K; Du Y; Bao X; Han M; Su R; Pang J; Liu S; Shi Z; Yan F; Feng S
    Small; 2022 Apr; 18(13):e2106558. PubMed ID: 35119204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting PDK1 with dichloroacetophenone to inhibit acute myeloid leukemia (AML) cell growth.
    Qin L; Tian Y; Yu Z; Shi D; Wang J; Zhang C; Peng R; Chen X; Liu C; Chen Y; Huang W; Deng W
    Oncotarget; 2016 Jan; 7(2):1395-407. PubMed ID: 26593251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
    Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
    Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.